查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1929520

人工智慧內視鏡市場按類型、產品類型、組件、成像技術、應用和最終用戶分類，全球預測（2026-2032年）

AI Endoscope Market by Type, Product Type, Component, Imaging Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，人工智慧內視鏡市場價值將達到 10.5 億美元，到 2026 年將成長至 11.3 億美元，到 2032 年將達到 16.5 億美元，年複合成長率為 6.59%。

關鍵市場統計數據
基準年 2025 10.5億美元
預計年份：2026年 11.3億美元
預測年份 2032 16.5億美元
複合年成長率 (%) 6.59%

本文簡要概述了光學創新、數位整合和臨床重點如何融合，從而重新定義內視鏡在現代醫學中的效用和採購方式。

臨床診斷影像領域正邁入一個新階段，先進的光學技術、計算影像處理和協作工作流程正在融合，重塑臨床醫生觀察和治療體內結構的方式。內視鏡已從獨立的光學儀器發展成為整合平台，整合了高清感測器、照明系統、處理器以及日益複雜的軟體層。隨著醫療系統致力於改善治療效果、縮短手術時間並控制成本，這些工具正在重新設計，以支持各個專科的微創治療。

影像技術的進步、感染控制的需求以及供應鏈的韌性正在如何改變醫療機構中內視鏡的設計、部署和採購方式？

內視鏡市場正經歷著一場變革性的轉變，這場轉變由多種相互作用的因素所驅動，正在改變產品設計、臨床工作流程和商業策略。首先，對更清晰影像的需求正在加速高解析度感測器和3D成像技術的應用，從而實現更精準的診斷和治療性介入。這種視覺清晰度，結合影像增強和即時分析等電腦輔助技術，正在提升臨床醫生的決策能力，並減少操作者之間的差異。

分析 2025 年關稅變化如何重塑採購方式、定價策略和監管途徑，從而推動製造商和醫療保健系統進行策略調整。

2025年關稅對醫療設備業的採購趨勢和供應鏈結構產生了顯著影響，尤其對內視鏡等複雜、資本密集產品的影響更為強烈。為此，製造商和醫療系統重新評估了其籌資策略，以控制成本風險並最大限度地減少業務中斷。許多供應商加快了製造地多元化、投資區域組裝能力或將零件採購轉移到受影響關稅區以外的地區等舉措，以保持價格競爭力和服務前置作業時間。

詳細的細分分析揭示了設備形態、臨床應用、使用者環境、組件生態系統和成像方式如何驅動差異化價值和購買行為。

細分市場分析揭示了產品形態、臨床應用、最終用戶、產品生命週期策略、組件架構和成像方式如何對設計選擇和市場推廣策略施加不同的影響。形態因素將市場細分為軟式內視鏡視鏡和硬式內視鏡，其中軟式內視鏡通常又可細分為可重複使用和一次性使用，這種二元性迫使供應商在可重複使用性和一次性產品的便利性之間取得平衡。關節鏡、胃腸內視鏡、婦科、腹腔鏡和泌尿系統等應用領域具有顯著不同的臨床需求，這為針對特定應用的光學設計、人體工學和配件生態系統創造了機會。

臨床基礎設施、採購慣例和法規環境的區域差異如何決定全球採用路徑和供應商價值提案

區域趨勢對產品採納、監管路徑、報銷框架和供應商策略均有顯著影響。在美洲，成熟的醫院系統和門診手術中心優先考慮與電子健康記錄的整合、高通量再處理流程以及臨床效益的證據。因此，供應商通常強調服務協議、培訓計劃和總成本考量。放眼東方，歐洲、中東和非洲地區呈現出多元化的格局，歐洲部分地區的監管趨於統一，而其他次區域的採購模式和基礎架構層存在差異。在這些地區，支付方和醫療機構會綜合考慮臨床療效、國家採購法規以及當地的生產和供應情況來評估醫療器材。

檢驗內視鏡市場的競爭、夥伴關係主導的創新以及服務導向商業模式如何重新定義供應商定位和客戶期望。

內視鏡市場的競爭格局呈現出複雜多樣的特點，既有老牌廠商，也有新興的專業公司，還有試圖利用數位化和一次性使用趨勢來搶佔市場佔有率的新參與企業。老牌廠商持續投資於光學性能、耐用性和服務網路的改進，專注於與大型醫療系統建立長期合作關係，並提供複雜的服務。同時，小規模、更靈活的廠商則利用一次性技術、特定應用設備和針對性的臨床夥伴關係，加速在特定細分市場的推廣應用。

在不斷變化的醫療保健環境中，製造商和供應商需要採取具體的策略行動來延長產品壽命、增強供應韌性、加速臨床應用並提高商業性柔軟性。

產業領導者應優先採取一系列切實可行的措施，以提升臨床價值、降低營運風險並鞏固市場地位。首先，應有選擇地投資於模組化、互通性的架構，使攝影機、處理器、顯示器和配件等組件能夠獨立昇級。這不僅能降低產品過時的風險，還能讓產品藍圖與醫院的IT生命週期一致。其次，應針對可重複使用和一次性產品製定清晰、基於實證的價值提案，透明地闡述感染預防措施、再處理負擔和環境影響，從而幫助採購方做出明智的權衡決策。

採用嚴謹的混合方法研究方法，結合臨床醫師訪談、技術檢驗和多學科檢驗方法，得出可操作且檢驗的市場洞察。

本研究綜合運用混合方法，結合關鍵相關人員訪談、專家小組諮詢和嚴謹的二手資料分析，以確保研究結果的平衡性和觀點。主要工作包括對各外科專科的臨床醫生、醫院和門診手術中心的採購主管以及醫療設備製造商和分銷商的高級管理人員進行結構化訪談。此外，還與臨床工程師和再處理專家舉行了技術審查會議，檢驗營運影響和生命週期的考量，從而補充了這些定性研究結果。

本文簡要概述了技術、營運和政策力量如何匯聚，從而推動兼具臨床療效和具有韌性、以服務為導向的經營模式的解決方案的出現。

總之，內視鏡領域正處於策略轉折點，光學創新、數位化、感染預防和供應鏈適應性將共同決定哪些解決方案將在醫療保健領域佔據主導地位。可重複使用和一次性使用模式之間的相互作用仍將是核心主題，並受到臨床證據、環境因素和組織優先事項的影響。同時，影像技術的進步，特別是3D視覺化和計算支援的進步，有望提升臨床能力，但需要明確證明其能改善臨床結果，才能證明其高價應用的合理性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 人工智慧內視鏡市場（按類型分類）

  • 靈活的
    • 可重複使用的
    • 一次性
  • 硬度

第9章 人工智慧內視鏡市場（依產品類型分類）

  • 可重複使用的
  • 一次性

第10章 人工智慧內視鏡市場（按組件分類）

  • 配件
  • 相機
  • 供氣設備
  • 光源
  • 監視器
  • 處理器

第11章 人工智慧內視鏡市場（依影像技術分類）

  • 2D成像
  • 3D成像

第12章 人工智慧內視鏡市場（按應用分類）

  • 關節鏡
  • 胃腸內視鏡檢查
  • 婦科
  • 腹腔鏡
  • 泌尿系統

第13章 人工智慧內視鏡市場（按最終用戶分類）

  • 門診手術中心
  • 診所
  • 診斷中心
  • 醫院

第14章 人工智慧內視鏡市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 人工智慧內視鏡市場（按組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國人工智慧內視鏡市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國人工智慧內視鏡市場

第18章：中國的人工智慧內視鏡市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Arthrex Inc.
  • Boston Scientific Corporation
  • CONMED Corporation
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hoya Corporation
  • Intuitive Surgical Inc.
  • Johnson & Johnson
  • Karl Storz SE & Co. KG
  • Medtronic plc
  • Olympus Corporation
  • Philips Healthcare
  • Richard Wolf GmbH
  • Siemens Healthineers AG
  • Smith & Nephew plc
  • Stryker Corporation
  • Zimmer Biomet Holdings Inc.
Product Code: MRR-0A38069517F0

The AI Endoscope Market was valued at USD 1.05 billion in 2025 and is projected to grow to USD 1.13 billion in 2026, with a CAGR of 6.59%, reaching USD 1.65 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.05 billion
Estimated Year [2026] USD 1.13 billion
Forecast Year [2032] USD 1.65 billion
CAGR (%) 6.59%

A concise overview of how optical innovation, digital integration, and clinical priorities are converging to redefine endoscope utility and procurement in modern care

The clinical imaging landscape is moving into a new phase where advanced optics, computational imaging, and connected workflows converge to reshape how clinicians visualize and treat internal anatomy. Endoscopes have evolved from standalone optical devices into integrated platforms that combine high-fidelity sensors, lighting systems, processors, and increasingly intelligent software layers. As healthcare systems seek to improve outcomes, reduce procedural time, and manage costs, these tools are being redesigned to support minimally invasive care across a broad spectrum of specialties.

Technological advances are enabling richer intraoperative visualization, and at the same time manufacturers are reimagining device lifecycles, service models, and supply chains. Adoption patterns vary by clinical application, setting, and economic context, yet a common theme is the drive toward more efficient, safer, and data-rich procedures. Clinicians and procurement teams are balancing clinical benefits with device ergonomics, reprocessing burden, and total cost of ownership. In this context, a strategic view of endoscope innovation is essential for stakeholders who must align patient safety, regulatory compliance, and commercial viability.

Consequently, stakeholders must consider not only optical and mechanical performance but also digital interoperability, disposable versus reusable trade-offs, and the implications of emerging reimbursement and procurement frameworks. These factors collectively influence how technologies will be adopted and which business models will succeed in the near to mid term.

How imaging advancements, infection control imperatives, and supply chain resilience are collectively reshaping endoscope design, adoption, and procurement across care settings

The endoscope market is undergoing transformative shifts driven by several intersecting forces that are altering product design, clinical workflows, and commercial strategies. First, the push for enhanced visualization has accelerated adoption of higher-resolution sensors and three-dimensional imaging capabilities, enabling more precise diagnostics and therapeutic interventions. This visual clarity is increasingly paired with computational assistance, such as image enhancement and real-time analytics, which augment clinician decision-making and reduce variability across operators.

Second, infection prevention concerns and operational efficiency are reshaping demand toward single-use options in many settings, while hybrid approaches combining reusable cores with disposable components are gaining traction. At the same time, tighter hospital budgets and emphasis on procedure throughput are steering adoption toward solutions that lower reprocessing costs and reduce turnaround times. Third, the digitization of operating rooms and integration with hospital information systems require endoscopes and their processors to communicate seamlessly with broader clinical IT environments, influencing procurement criteria and vendor selection.

Finally, global supply chain resilience and regional manufacturing strategies are becoming central to vendor value propositions. Providers increasingly evaluate suppliers not only on device performance but also on controllable logistics, spare parts availability, and service responsiveness. Taken together, these shifts create opportunities for innovators who can deliver clinically differentiated imaging, pragmatic infection-control solutions, and robust support models that align with institutional priorities.

An analysis of how tariff changes in 2025 reshaped sourcing, pricing tactics, and regulatory pathways, prompting strategic adjustments across manufacturers and health systems

Tariff policies adopted in 2025 have had a tangible influence on procurement dynamics and supply chain configurations across the medical device sector, with particular implications for complex capital-intensive products such as endoscopes. In response, manufacturers and health systems have revisited sourcing strategies to manage cost exposure and minimize operational disruption. Many suppliers accelerated efforts to diversify manufacturing footprints, invest in regional assembly capabilities, or shift component sourcing to jurisdictions outside of affected tariff zones to preserve competitive pricing and service lead times.

Concurrently, hospital procurement teams have intensified scrutiny of landed costs, total cost of ownership, and contractual protections against future tariff volatility. Where tariffs increased landed costs, some institutions leaned toward contractual hedges and multi-year agreements to stabilize procurement budgets. Others experimented with alternative product mixes, including greater use of single-use endoscopes where logistical simplicity and predictable per-case costing offset higher per-unit prices.

Moreover, regulatory and compliance considerations shaped responses, as repatriation or regionalization of production required new validations, quality audits, and documentation to meet local market requirements. These incremental compliance burdens extended timelines for product introductions in certain jurisdictions, prompting manufacturers to prioritize product lines with the clearest clinical and economic value. Overall, the cumulative tariff-driven effects emphasized the strategic importance of manufacturing agility, robust supplier networks, and clear communication between commercial, regulatory, and supply chain teams.

Detailed segmentation insights demonstrating how device form, clinical application, user setting, component ecosystems, and imaging modality drive differentiated value and purchasing behavior

Segmentation analysis reveals how product form, clinical application, end user, product lifecycle strategy, component architecture, and imaging modality each exert distinct pressures on design choices and go-to-market approaches. When considering type, the market differentiates between flexible and rigid endoscopes, with flexible devices often subdivided into reusable and single-use forms; this duality forces vendors to balance reprocessing capabilities against disposability-driven convenience. Across applications such as arthroscopy, gastrointestinal endoscopy, gynecology, laparoscopy, and urology, clinical requirements diverge significantly, creating opportunities for application-specific optics, ergonomics, and accessory ecosystems.

End users show heterogeneous priorities: ambulatory surgical centers and clinics typically emphasize throughput and per-procedure cost predictability, diagnostic centers prioritize image fidelity and reporting workflows, while hospitals demand robustness, serviceability, and integration with complex IT systems. Product type discussions return repeatedly to the reusable versus single-use debate, where life-cycle costs, infection prevention protocols, and environmental considerations shape procurement decisions. Component segmentation underscores the importance of modular architectures; accessories, cameras, insufflators, light sources, monitors, and processors represent distinct value pools that can be bundled or sold independently depending on customer needs and service strategies.

Finally, imaging technology choices between 2D and 3D imaging create different clinical narratives: 2D systems prioritize proven compatibility and cost-effectiveness, while 3D imaging targets surgical specialties that benefit from depth perception and enhanced spatial orientation. Taken together, these segmentation lenses provide a nuanced map for product development, clinical validation, and targeted commercial messaging.

How regional variations in clinical infrastructure, procurement practices, and regulatory environments are defining adoption pathways and supplier value propositions worldwide

Regional dynamics materially influence product adoption, regulatory pathways, reimbursement frameworks, and supplier strategies. In the Americas, established hospital systems and ambulatory surgical centers prioritize integration with electronic health records, high-throughput reprocessing workflows, and evidence demonstrating clinical benefit; consequently, suppliers often emphasize service contracts, training programs, and total cost considerations. Transitioning eastward, Europe, Middle East & Africa presents a heterogeneous landscape where regulatory harmonization in parts of Europe contrasts with disparate procurement models and infrastructure levels in other subregions. Here, payers and institutions evaluate devices through a mix of clinical efficacy, national procurement rules, and local manufacturing or supply considerations.

Across Asia-Pacific, rapid hospital expansion, rising procedural volumes, and varying regulatory maturity create both opportunities and complexities for vendors. Some markets within the region are highly cost-sensitive and favor pragmatic single-use options or lower-cost 2D imaging systems, while others are investing aggressively in high-end visualization and 3D platforms to support advanced surgical programs. Supply chain geography also matters; proximity to manufacturing hubs can shorten lead times and influence competitive positioning. In summary, regional strategies must align product portfolios, pricing models, and regulatory roadmaps with the distinct clinical, economic, and infrastructural realities of each territory.

Examining competitive dynamics, partnership-led innovation, and service-oriented commercial models that are redefining supplier positioning and customer expectations in the endoscope market

Competitive dynamics in the endoscope landscape are characterized by a mix of legacy incumbents, emerging specialists, and new entrants leveraging digital and disposability trends to gain share. Established manufacturers continue to invest in incremental improvements across optics, durability, and service networks, focusing on long-standing relationships with large health systems and complex service offerings. At the same time, smaller and more agile players are capitalizing on single-use technologies, application-specific devices, and targeted clinical partnerships to accelerate adoption in focused niches.

Partnerships between imaging specialists and software or analytics firms have become common, as vendors seek to deliver clinically meaningful workflows rather than isolated hardware. Service-led business models, including subscription-based access to imaging platforms and outcome-linked contracting, are gaining attention as purchasers look to align costs with utilization and clinical performance. Additionally, aftermarket components and accessory ecosystems represent high-margin areas where suppliers can differentiate through compatibility, ease of use, and bundled training.

Finally, strategic M&A activity and distribution alliances continue to reshape the competitive map. Companies that combine manufacturing scale with software prowess and regional service depth are increasingly positioned to win institutional contracts. For decision-makers, the critical lens should be on supplier reliability, clarity of upgrade and service paths, and demonstrable clinical outcomes rather than on isolated product specifications.

Concrete strategic actions for manufacturers and providers to improve product longevity, supply resilience, clinical adoption, and commercial flexibility in evolving care settings

Industry leaders should prioritize a set of practical, actionable moves to capture clinical value, mitigate operational risk, and strengthen market position. First, invest selectively in modular and interoperable architectures that allow components such as cameras, processors, monitors, and accessories to be upgraded independently; this reduces obsolescence risk and aligns product roadmaps with hospital IT lifecycles. Second, develop clear, evidence-based value propositions for reusable versus single-use offerings that transparently account for infection prevention, reprocessing burdens, and environmental impacts so that buyers can make informed trade-offs.

Third, build resilient supply chains by diversifying manufacturing and assembly locations while strengthening supplier relationships for critical subcomponents to minimize tariff and logistics exposure. Fourth, emphasize post-sale support models that include training, preventive maintenance, and rapid parts replacement to underpin long-term contracts with major health systems. Fifth, pursue targeted clinical collaborations to validate advanced imaging features such as 3D visualization and AI-assisted analytics in high-impact procedures; real-world evidence will accelerate adoption and justify premium positioning.

Finally, adopt flexible commercial models, including leasing, outcome-based agreements, and bundled service contracts that align with purchaser preferences across ambulatory centers, clinics, diagnostic centers, and hospitals. Executing on these recommendations will require cross-functional alignment among product, regulatory, and commercial teams but will materially improve competitiveness and relevance in a rapidly evolving market.

A rigorous mixed-methods research approach integrating clinician interviews, technical validations, and multi-source triangulation to produce practical and verifiable market insights

This research synthesizes insights from a mixed-methods approach combining primary stakeholder interviews, expert panel consultations, and rigorous secondary-source analysis to ensure a balanced and actionable perspective. Primary engagements included structured interviews with clinicians across surgical specialties, procurement leaders from hospitals and ambulatory surgical centers, and senior executives from device manufacturers and distributors. These qualitative inputs were complemented by technical review sessions with clinical engineers and reprocessing specialists to validate operational implications and lifecycle considerations.

Secondary analysis encompassed regulatory filings, peer-reviewed clinical literature on imaging and infection control, device technology white papers, and public filings that illuminate company strategies and product claims. Data were triangulated across sources to identify consistent patterns and to reconcile divergent viewpoints. Special attention was given to regional regulatory frameworks and supply chain constraints to ensure that geographic insights reflect real-world constraints and opportunities.

Throughout the process, methodological safeguards were applied to minimize bias, including cross-validation of interview findings, anonymization of sensitive inputs to encourage candor, and iterative review cycles with clinical experts. Limitations are acknowledged: evolving tariff and regulatory landscapes may shift operational details, and local procurement idiosyncrasies can affect transferability. Nevertheless, the methodology supports robust, practical conclusions that can inform strategic planning and vendor selection.

A concise summation of how technological, operational, and policy forces converge to favor solutions that pair clinical impact with resilient, service-oriented business models

In conclusion, the endoscope sector is at a strategic inflection point where optical innovation, digitization, infection prevention, and supply chain adaptability collectively determine which solutions gain traction across care settings. The interplay between reusable and single-use paradigms will remain a central theme, shaped by clinical evidence, environmental considerations, and institutional priorities. Meanwhile, advancements in imaging technology, especially 3D visualization and computational assistance, promise to augment clinical capabilities but will require clear demonstration of outcome improvements to justify premium adoption.

Regional nuances and policy shifts-such as tariff-driven supply chain adjustments-underscore the importance of manufacturing flexibility and transparent total cost discussions between vendors and purchasers. Suppliers that can pair clinical differentiation with robust service models and flexible commercial arrangements will be best positioned to win long-term relationships with hospitals, ambulatory surgical centers, and diagnostic facilities. For clinical leaders, procurement teams, and investors, the critical focus should be on solutions that deliver measurable clinical benefits, integrate effectively into digital workflows, and present defensible value propositions when evaluated against operational realities.

Ultimately, successful market participants will be those that combine technical excellence with pragmatic business models, clear evidence generation, and resilient operational infrastructures.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. AI Endoscope Market, by Type

  • 8.1. Flexible
    • 8.1.1. Reusable
    • 8.1.2. Single Use
  • 8.2. Rigid

9. AI Endoscope Market, by Product Type

  • 9.1. Reusable
  • 9.2. Single Use

10. AI Endoscope Market, by Component

  • 10.1. Accessories
  • 10.2. Camera
  • 10.3. Insufflator
  • 10.4. Light Source
  • 10.5. Monitor
  • 10.6. Processor

11. AI Endoscope Market, by Imaging Technology

  • 11.1. 2D Imaging
  • 11.2. 3D Imaging

12. AI Endoscope Market, by Application

  • 12.1. Arthroscopy
  • 12.2. Gastrointestinal Endoscopy
  • 12.3. Gynecology
  • 12.4. Laparoscopy
  • 12.5. Urology

13. AI Endoscope Market, by End User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Clinics
  • 13.3. Diagnostic Centers
  • 13.4. Hospitals

14. AI Endoscope Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. AI Endoscope Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. AI Endoscope Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States AI Endoscope Market

18. China AI Endoscope Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Arthrex Inc.
  • 19.6. Boston Scientific Corporation
  • 19.7. CONMED Corporation
  • 19.8. Fujifilm Holdings Corporation
  • 19.9. GE HealthCare Technologies Inc.
  • 19.10. Hoya Corporation
  • 19.11. Intuitive Surgical Inc.
  • 19.12. Johnson & Johnson
  • 19.13. Karl Storz SE & Co. KG
  • 19.14. Medtronic plc
  • 19.15. Olympus Corporation
  • 19.16. Philips Healthcare
  • 19.17. Richard Wolf GmbH
  • 19.18. Siemens Healthineers AG
  • 19.19. Smith & Nephew plc
  • 19.20. Stryker Corporation
  • 19.21. Zimmer Biomet Holdings Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL AI ENDOSCOPE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AI ENDOSCOPE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL AI ENDOSCOPE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL AI ENDOSCOPE MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL AI ENDOSCOPE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AI ENDOSCOPE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL AI ENDOSCOPE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL AI ENDOSCOPE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES AI ENDOSCOPE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA AI ENDOSCOPE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL AI ENDOSCOPE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL AI ENDOSCOPE MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL AI ENDOSCOPE MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AI ENDOSCOPE MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AI ENDOSCOPE MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AI ENDOSCOPE MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL AI ENDOSCOPE MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL AI ENDOSCOPE MARKET SIZE, BY RIGID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL AI ENDOSCOPE MARKET SIZE, BY RIGID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL AI ENDOSCOPE MARKET SIZE, BY RIGID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL AI ENDOSCOPE MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AI ENDOSCOPE MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL AI ENDOSCOPE MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL AI ENDOSCOPE MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL AI ENDOSCOPE MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL AI ENDOSCOPE MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL AI ENDOSCOPE MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL AI ENDOSCOPE MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL AI ENDOSCOPE MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL AI ENDOSCOPE MARKET SIZE, BY CAMERA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL AI ENDOSCOPE MARKET SIZE, BY CAMERA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL AI ENDOSCOPE MARKET SIZE, BY CAMERA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL AI ENDOSCOPE MARKET SIZE, BY INSUFFLATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL AI ENDOSCOPE MARKET SIZE, BY INSUFFLATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL AI ENDOSCOPE MARKET SIZE, BY INSUFFLATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL AI ENDOSCOPE MARKET SIZE, BY LIGHT SOURCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL AI ENDOSCOPE MARKET SIZE, BY LIGHT SOURCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL AI ENDOSCOPE MARKET SIZE, BY LIGHT SOURCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL AI ENDOSCOPE MARKET SIZE, BY MONITOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AI ENDOSCOPE MARKET SIZE, BY MONITOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AI ENDOSCOPE MARKET SIZE, BY MONITOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AI ENDOSCOPE MARKET SIZE, BY PROCESSOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AI ENDOSCOPE MARKET SIZE, BY PROCESSOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL AI ENDOSCOPE MARKET SIZE, BY PROCESSOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AI ENDOSCOPE MARKET SIZE, BY 2D IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL AI ENDOSCOPE MARKET SIZE, BY 2D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL AI ENDOSCOPE MARKET SIZE, BY 2D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL AI ENDOSCOPE MARKET SIZE, BY 3D IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AI ENDOSCOPE MARKET SIZE, BY 3D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL AI ENDOSCOPE MARKET SIZE, BY 3D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL AI ENDOSCOPE MARKET SIZE, BY ARTHROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL AI ENDOSCOPE MARKET SIZE, BY ARTHROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL AI ENDOSCOPE MARKET SIZE, BY ARTHROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL AI ENDOSCOPE MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AI ENDOSCOPE MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL AI ENDOSCOPE MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL AI ENDOSCOPE MARKET SIZE, BY GYNECOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL AI ENDOSCOPE MARKET SIZE, BY GYNECOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AI ENDOSCOPE MARKET SIZE, BY GYNECOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AI ENDOSCOPE MARKET SIZE, BY LAPAROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AI ENDOSCOPE MARKET SIZE, BY LAPAROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL AI ENDOSCOPE MARKET SIZE, BY LAPAROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL AI ENDOSCOPE MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL AI ENDOSCOPE MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL AI ENDOSCOPE MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AI ENDOSCOPE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL AI ENDOSCOPE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL AI ENDOSCOPE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL AI ENDOSCOPE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL AI ENDOSCOPE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL AI ENDOSCOPE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL AI ENDOSCOPE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL AI ENDOSCOPE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL AI ENDOSCOPE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL AI ENDOSCOPE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL AI ENDOSCOPE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL AI ENDOSCOPE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL AI ENDOSCOPE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS AI ENDOSCOPE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA AI ENDOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA AI ENDOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA AI ENDOSCOPE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE AI ENDOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST AI ENDOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA AI ENDOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC AI ENDOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL AI ENDOSCOPE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN AI ENDOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. GCC AI ENDOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GCC AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. GCC AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 155. GCC AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. GCC AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 157. GCC AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. GCC AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. GCC AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION AI ENDOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS AI ENDOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. G7 AI ENDOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. G7 AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. G7 AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 179. G7 AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. G7 AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 181. G7 AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. G7 AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. G7 AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. NATO AI ENDOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. NATO AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. NATO AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 187. NATO AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. NATO AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 189. NATO AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. NATO AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. NATO AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL AI ENDOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES AI ENDOSCOPE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA AI ENDOSCOPE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)